Published in Medical Letter on the CDC and FDA, November 1st, 2009
Selzentry was originally approved by the FDA in August 2007 as a salvage drug-utilized in patients who do not respond favorably, or have developed resistance, to other AIDS drugs-and priced at...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA